120 related articles for article (PubMed ID: 38295667)
1. Decisions and prompts to screen for cervical, bowel, and breast cancer.
Anderson LE; Collins KE; Myers L; Ireland MJ; Omar M; Drummond A; Goodwin BC
Patient Educ Couns; 2024 May; 122():108174. PubMed ID: 38295667
[TBL] [Abstract][Full Text] [Related]
2. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study.
McCowan C; McSkimming P; Papworth R; Kotzur M; McConnachie A; Macdonald S; Wyke S; Crighton E; Campbell C; Weller D; Steele RJC; Robb KA
Br J Cancer; 2019 Oct; 121(8):710-714. PubMed ID: 31481732
[TBL] [Abstract][Full Text] [Related]
3. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
[TBL] [Abstract][Full Text] [Related]
5. Methods to increase participation in organised screening programs: a systematic review.
Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
[TBL] [Abstract][Full Text] [Related]
6. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
7. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
Elife; 2022 Jun; 11():. PubMed ID: 35762572
[TBL] [Abstract][Full Text] [Related]
8. The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer.
Whitham HK; Kulasingam SL
Prev Med; 2015 Jul; 76():135-40. PubMed ID: 25937628
[TBL] [Abstract][Full Text] [Related]
9. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
[TBL] [Abstract][Full Text] [Related]
10. Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial.
Biederman E; Baltic R; Katz ML; Rawl S; Vachon E; Monahan PO; Stump TE; Kettler C; Carter L; Young G; Xu W; Paskett ED; Champion V
Contemp Clin Trials; 2022 Dec; 123():106986. PubMed ID: 36328234
[TBL] [Abstract][Full Text] [Related]
11. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study.
Kotzur M; McCowan C; Macdonald S; Wyke S; Gatting L; Campbell C; Weller D; Crighton E; Steele RJC; Robb KA
BMJ Qual Saf; 2020 Jun; 29(6):482-490. PubMed ID: 31879320
[TBL] [Abstract][Full Text] [Related]
12. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
Lo SH; Waller J; Wardle J; von Wagner C
J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
[TBL] [Abstract][Full Text] [Related]
13. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
14. A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
Nickson C; Smith MA; Feletto E; Velentzis LS; Broun K; Deij S; Grogan P; Hall M; He E; St John DJ; Lew JB; Procopio P; Simms KT; Worthington J; Mann GB; Canfell K
Elife; 2023 Apr; 12():. PubMed ID: 37022767
[TBL] [Abstract][Full Text] [Related]
15. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders.
Baron RC; Melillo S; Rimer BK; Coates RJ; Kerner J; Habarta N; Chattopadhyay S; Sabatino SA; Elder R; Leeks KJ;
Am J Prev Med; 2010 Jan; 38(1):110-7. PubMed ID: 20117566
[TBL] [Abstract][Full Text] [Related]
16. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
[No Abstract] [Full Text] [Related]
17. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.
Schapira MM; Sprague BL; Klabunde CN; Tosteson AN; Bitton A; Chen JS; Beaber EF; Onega T; MacLean CD; Harris K; Howe K; Pearson L; Feldman S; Brawarsky P; Haas JS;
J Gen Intern Med; 2016 Oct; 31(10):1148-55. PubMed ID: 27251058
[TBL] [Abstract][Full Text] [Related]
18. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
19. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
20. Cancer Screening Test Use-U.S., 2019.
Sabatino SA; Thompson TD; White MC; Shapiro JA; Clarke TC; Croswell JM; Richardson LC
Am J Prev Med; 2022 Sep; 63(3):431-439. PubMed ID: 35469700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
